HOUSTON, Nov. 21 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Vice President, Finance and Chief Financial Officer, will present at the Piper Jaffray 20th Annual Health Care Conference in New York on Tuesday, December 2, 2008 at 1:00 PM EST. The conference session and webcast will be audio only and no formal slides will be presented. Piper Jaffray will host a webcast of the presentation live and by replay at http://www.piperjaffray.com/conferences. The conference webcast replay will be available for 30 days following the conference. The presentation can also be accessed at http://www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.
ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
CONTACT INFORMATION: Greg Browne, CFO Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281) 228-7262 Fax: (281) 218-9332 firstname.lastname@example.org
|SOURCE Cyberonics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved